166 related articles for article (PubMed ID: 3015709)
1. Immunohistochemical study of neuron-specific enolase and CA 19-9 in pancreatic disorders. The value of neuron-specific enolase as a marker for islet cell and nerve tissue.
Iwase K; Kato K; Nagasaka A; Miura K; Kawase K; Miyakawa S; Tei T; Ohtani S; Inagaki M; Shinoda S
Gastroenterology; 1986 Sep; 91(3):576-80. PubMed ID: 3015709
[TBL] [Abstract][Full Text] [Related]
2. Serum markers for pancreatic islet cell and intestinal carcinoid tumors: a comparison of neuron-specific enolase, beta-human chorionic gonadotropin and pancreatic polypeptide.
Prinz RA; Bermes EW; Kimmel JR; Marangos PJ
Surgery; 1983 Dec; 94(6):1019-23. PubMed ID: 6196846
[TBL] [Abstract][Full Text] [Related]
3. Serum neuron-specific enolase: a serum marker for nonfunctioning pancreatic islet cell carcinoma.
Prinz RA; Marangos PJ
Am J Surg; 1983 Jan; 145(1):77-81. PubMed ID: 6295198
[TBL] [Abstract][Full Text] [Related]
4. Chromogranin A plasma concentration and expression in pancreatic islet cell tumors of dogs and cats.
Myers NC; Andrews GA; Chard-Bergstrom C
Am J Vet Res; 1997 Jun; 58(6):615-20. PubMed ID: 9185968
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical localization of neuron-specific enolase in gastroenteropancreatic neuroendocrine tumors. Correlation with tissue and serum levels of neuron-specific enolase.
Simpson S; Vinik AI; Marangos PJ; Lloyd RV
Cancer; 1984 Oct; 54(7):1364-9. PubMed ID: 6088026
[TBL] [Abstract][Full Text] [Related]
6. [Synaptophysin, chromogranin A and neuron-specific enolase as tumor markers in neuroendocrine tumors of the gastrointestinal tract and lung. An immunohistochemical study].
Eberlein-Gonska M; Wiedenmann B; Waldherr R
Pathologe; 1989 Jul; 10(4):228-33. PubMed ID: 2549534
[No Abstract] [Full Text] [Related]
7. 7B2, a possible marker for nonfunctioning pancreatic islet cell tumor.
Iguchi H; Yasuda D; Yamada Y; Funakoshi A; Wakasugi H; Bloom SR; Chretien M
Horm Metab Res; 1991 Oct; 23(10):486-9. PubMed ID: 1662184
[TBL] [Abstract][Full Text] [Related]
8. High sensitivity and specificity of CA 19-9 for pancreatic carcinoma in comparison to chronic pancreatitis. Serological and immunohistochemical findings.
Safi F; Roscher R; Bittner R; Schenkluhn B; Dopfer HP; Beger HG
Pancreas; 1987; 2(4):398-403. PubMed ID: 3306667
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic polypeptide in islet cell tumors. Morphologic and functional correlations.
Tomita T; Kimmel JR; Friesen SR; Doull V; Pollock HG
Cancer; 1985 Oct; 56(7):1649-57. PubMed ID: 2992743
[TBL] [Abstract][Full Text] [Related]
10. Cytokeratin 19 fragment CYFRA 21-1 compared with carcinoembryonic antigen, squamous cell carcinoma antigen and neuron-specific enolase in lung cancer. Results of an international multicentre study.
Ebert W; Dienemann H; Fateh-Moghadam A; Scheulen M; Konietzko N; Schleich T; Bombardieri E
Eur J Clin Chem Clin Biochem; 1994 Mar; 32(3):189-99. PubMed ID: 7518259
[TBL] [Abstract][Full Text] [Related]
11. Tissue expression of the tumour associated antigen CA242 in benign and malignant pancreatic lesions. A comparison with CA 50 and CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Kuusela P; Nordling S
Br J Cancer; 1989 Dec; 60(6):845-51. PubMed ID: 2557879
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and prognostic significance of acinar cell differentiation in pancreatic endocrine tumors.
Yantiss RK; Chang HK; Farraye FA; Compton CC; Odze RD
Am J Surg Pathol; 2002 Jul; 26(7):893-901. PubMed ID: 12131156
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of serum pancreatic enzymes, carbohydrate antigen 19-9, and carcinoembryonic antigen in various pancreatic diseases.
Satake K; Kanazawa G; Kho I; Chung Y; Umeyama K
Am J Gastroenterol; 1985 Aug; 80(8):630-6. PubMed ID: 2411125
[TBL] [Abstract][Full Text] [Related]
14. Serum neuron-specific enolase in "non-functioning" islet-cell carcinoma.
Prinz RA; Marangos PJ
Lancet; 1982 Feb; 1(8267):340. PubMed ID: 6120337
[No Abstract] [Full Text] [Related]
15. Neuropilin-2 is a novel marker expressed in pancreatic islet cells and endocrine pancreatic tumours.
Cohen T; Herzog Y; Brodzky A; Greenson JK; Eldar S; Gluzman-Poltorak Z; Neufeld G; Resnick MB
J Pathol; 2002 Sep; 198(1):77-82. PubMed ID: 12210066
[TBL] [Abstract][Full Text] [Related]
16. Concentration and localization of carbohydrate antigen 19-9 in tissues of pancreatic cancer.
Nishida K; Miyagawa H; Yoshikawa T; Kondo M
Oncology; 1988; 45(3):166-71. PubMed ID: 3163417
[TBL] [Abstract][Full Text] [Related]
17. Estimation of carbohydrate antigen (CA) 19-9 levels in pure pancreatic juice of patients with pancreatic cancer.
Nishida K; Tasaki N; Miyagawa H; Yoshikawa T; Kondo M
Am J Gastroenterol; 1988 Feb; 83(2):126-9. PubMed ID: 3422536
[TBL] [Abstract][Full Text] [Related]
18. Neuron-specific enolase (NSE) as a neuroendocrine cell marker in the human fetal pancreas.
von Dorsche HH; Fält K; Hahn HJ; Reiher H
Acta Histochem; 1989; 85(2):227-8. PubMed ID: 2500832
[TBL] [Abstract][Full Text] [Related]
19. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9.
Haglund C; Lindgren J; Roberts PJ; Nordling S
Int J Cancer; 1986 Dec; 38(6):841-6. PubMed ID: 3466871
[TBL] [Abstract][Full Text] [Related]
20. Alpha-human chorionic gonadotropin and neuron-specific enolase as markers for malignancy and neuroendocrine nature of pancreatic endocrine tumors.
Klöppel G; Girard J; Polak JM; Vaitukaitis JL; Kasper M; Heitz PU
Cancer Detect Prev; 1983; 6(1-2):161-6. PubMed ID: 6309383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
